FDA approves generic Strattera for ADHD
On May 30, the U.S. Food and Drug Administration (FDA) approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in…
Web Exclusives
Middle-school program reduces young adult substance abuse
Children who participated in the PROSPER (PROmoting School-community-university Partnerships to Enhance Resilience) program over seven years ago showed lower rates of substance abuse after…
FDA approves cancer treatment for tumors with specific biomarker
On May 23, the U.S. Food and Drug Administration (FDA) approved Keytruda (pembrolizumab) for the treatment of unresectable or metastatic solid tumors with the…
Intranasal oxytocin and emotional perception by patients with autism
Low-dose intranasal oxytocin can influence how patients with autism perceive emotion, according to a study in Translational Psychiatry. Read more and access the study.
Probiotics reduces depression in patients with IBS
A study in Gastroenterology reports that probiotics reduces depression in patients with irritable bowel syndrome (IBS) and increases quality of life. Read more
FDA expands approved use of Kalydeco for CF
On May 17, the U.S. Food and Drug Administration (FDA) expanded the approved use of Kalydeco (ivacaftor) for treating cystic fibrosis (CF), tripling the…
Number of women living with metastatic breast cancer growing
The number of women living with metastatic breast cancer increased by 4% from 1990 to 2000 and by 17% from 2000 to 2010, according…
Tree nuts may reduce risk of recurrent colon cancer
Patients who consume 2 or more ounces of tree nuts (for example, almonds, walnuts, hazelnuts, pecans, and cashews) per week lower their risk of…
FDA approves drug for ALS
On May 5, the U.S. Food and Drug Administration (FDA) approved Radicava (edaravone) to treat patients with amyotrophic lateral sclerosis (ALS). Read more
JAMA focuses on conflict of interest
The May 2 JAMA explores the issue of conflict of interest through several open-access articles. Access the articles.
Surgical caps and surgical site infections
Switching from surgical skull caps to bouffant caps doesn’t reduce surgical site infections, according to a study in Neurosurgery. Read more
Research 101: Forest plots
Patient care decisions must be made based on the current best evidence, and nurses critically appraise many kinds of research designs and their associated…
FDA approves generic Strattera for ADHD
On May 30, the U.S. Food and Drug Administration (FDA) approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder…
Middle-school program reduces young adult substance abuse
Children who participated in the PROSPER (PROmoting School-community-university Partnerships to Enhance Resilience) program over seven years ago showed lower rates of substance…
FDA approves cancer treatment for tumors with specific biomarker
On May 23, the U.S. Food and Drug Administration (FDA) approved Keytruda (pembrolizumab) for the treatment of unresectable or metastatic solid tumors…
Intranasal oxytocin and emotional perception by patients with autism
Low-dose intranasal oxytocin can influence how patients with autism perceive emotion, according to a study in Translational Psychiatry. Read more and access the study.
Probiotics reduces depression in patients with IBS
A study in Gastroenterology reports that probiotics reduces depression in patients with irritable bowel syndrome (IBS) and increases quality of life. Read…
FDA expands approved use of Kalydeco for CF
On May 17, the U.S. Food and Drug Administration (FDA) expanded the approved use of Kalydeco (ivacaftor) for treating cystic fibrosis (CF),…
Number of women living with metastatic breast cancer growing
The number of women living with metastatic breast cancer increased by 4% from 1990 to 2000 and by 17% from 2000 to…
Tree nuts may reduce risk of recurrent colon cancer
Patients who consume 2 or more ounces of tree nuts (for example, almonds, walnuts, hazelnuts, pecans, and cashews) per week lower their…
FDA approves drug for ALS
On May 5, the U.S. Food and Drug Administration (FDA) approved Radicava (edaravone) to treat patients with amyotrophic lateral sclerosis (ALS). Read…
JAMA focuses on conflict of interest
The May 2 JAMA explores the issue of conflict of interest through several open-access articles. Access the articles.
Surgical caps and surgical site infections
Switching from surgical skull caps to bouffant caps doesn’t reduce surgical site infections, according to a study in Neurosurgery. Read more
Research 101: Forest plots
Patient care decisions must be made based on the current best evidence, and nurses critically appraise many kinds of research designs and…
Poll
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.